VISN 12 New Blood and Blood Products Contract   2

Background
The Department of Veterans Affairs is seeking to establish a contract for the delivery of Blood and Blood Products to various facilities within VISN 12. This initiative aims to ensure that the medical centers have a reliable supply of essential blood products to support patient care and treatment. The locations involved include Jesse Brown VAMC, Lovell Federal Health Care Center, Hines VAMC, William S Middleton VAMC, Tomah VAMC, and Zablocki VAMC.

Work Details
The contract will cover the delivery of Blood and Blood Products as specified in RFQ# 36C25226Q0606. The specific types and quantities of blood products required will be detailed in the RFQ documentation. The following facilities are designated for delivery:
- Jesse Brown VAMC, 820 South Damen Ave, Chicago, IL 60612
- Lovell Federal Health Care Center, 3001 Green Bay Road, North Chicago, IL 60064
- Hines VAMC, 5000 South 5th Ave, Hines, IL 60141
- William S Middleton VAMC, 2500 Overlook Terrace, Madison, WI 53705
- Tomah VAMC, 500 E. Veterans Street, Tomah, WI 54660
- Zablocki VAMC, 5000 W. National Ave, Milwaukee WI 53295.

Period of Performance
The response date for this solicitation is set for August 12, 2026.

Place of Performance
820 South Damen Ave Chicago IL 60612

Bidder Requirements
Bidders must comply with any specific requirements outlined in the RFQ regarding authorized distributors or manufacturers of blood products.

Incumbent Analysis (see Incumbents section for more detail)
This opportunity for VISN 12 blood and blood products delivery appears to have a confirmed incumbent, Versiti Blood Health, based on multiple related awards under 36C25221D0071 ($2,413,526), 36C25221D0072 ($3,397,102), and 36C25221D0073 ($7,092,472) covering delivery of blood products to the same core VISN 12 facilities (Jesse Brown VAMC, Lovell Federal Health Care Center, Hines VAMC, William S. Middleton VAMC, Tomah VAMC, and Zablocki VAMC). The prior award descriptions indicate ongoing delivery of FDA/AABB-compliant blood components (e.g., leukoreduced red blood cells and plasma/platelets) with routine/timed service as specified in earlier VISN 12 RFQs. The current RFQ is likewise tied to RFQ# 36C25226Q0606 and lists the same facility set, suggesting continuity of the same supply-and-delivery requirement.